Alkermes plc. - ALKS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 09, 2026 | SVP, Chief Financial Officer | M | D | 9,164.0 | — | — | 27,492.0 | View | |
| Oct 09, 2026 | SVP, Chief Financial Officer | F | D | 4,069.0 | 40.11 | 163,207.59 | 5,095.0 | View | |
| Oct 09, 2026 | SVP, Chief Financial Officer | M | A | 9,164.0 | — | — | 9,164.0 | View | |
| Oct 09, 2026 | — | A | A | 17,998.0 | 0.0 | 0.0 | 17,998.0 | View | |
| Oct 09, 2026 | — | A | A | 7,239.0 | 0.0 | 0.0 | 7,239.0 | View | |
| Oct 02, 2026 | EVP, CLO, Alkermes, Inc. | S | D | 2,034.0 | 41.03 | 83,455.02 | 221,388.0 | View | |
| Sep 03, 2026 | EVP, CLO, Alkermes, Inc. | S | D | 2,034.0 | 48.01 | 97,652.34 | 223,422.0 | View | |
| Sep 01, 2026 | EVP R&D, Chief Medical Officer | M | D | 5,000.0 | 0.0 | 0.0 | 61,276.0 | View | |
| Sep 01, 2026 | EVP R&D, Chief Medical Officer | S | D | 9,000.0 | 46.986 | 422,874.0 | 65,389.0 | View | |
| Sep 01, 2026 | EVP R&D, Chief Medical Officer | M | A | 5,000.0 | 24.59 | 122,950.0 | 74,389.0 | View | |
| Aug 17, 2026 | SVP, Chief Commercial Officer | S | D | 664.0 | 49.6526 | 32,969.33 | 102,193.0 | View | |
| Aug 17, 2026 | SVP, Chief Commercial Officer | S | D | 6,912.0 | 49.1851 | 339,967.41 | 102,857.0 | View | |
| Aug 07, 2026 | President & CEO, Alkermes plc | A | A | 124,305.0 | 0.0 | 0.0 | 124,305.0 | View | |
| Aug 07, 2026 | President & CEO, Alkermes plc | A | A | 93,229.0 | 0.0 | 0.0 | 93,229.0 | View | |
| Aug 03, 2026 | — | M | D | 16,524.0 | 0.0 | 0.0 | 0.0 | View | |
| Aug 03, 2026 | — | M | D | 27,948.0 | 0.0 | 0.0 | 0.0 | View | |
| Aug 03, 2026 | — | S | D | 44,472.0 | 50.348 | 2,239,076.26 | 15,395.0 | View | |
| Aug 03, 2026 | — | M | A | 16,524.0 | 46.72 | 772,001.28 | 59,867.0 | View | |
| Aug 03, 2026 | — | M | A | 27,948.0 | 46.72 | 1,305,730.56 | 43,343.0 | View | |
| Aug 03, 2026 | EVP R&D, Chief Medical Officer | M | D | 4,896.0 | 0.0 | 0.0 | 66,276.0 | View | |
| Aug 03, 2026 | EVP R&D, Chief Medical Officer | M | D | 104.0 | 0.0 | 0.0 | 1,252.0 | View | |
| Aug 03, 2026 | EVP R&D, Chief Medical Officer | S | D | 9,000.0 | 48.58 | 437,220.0 | 69,389.0 | View | |
| Aug 03, 2026 | EVP R&D, Chief Medical Officer | M | A | 4,896.0 | 24.59 | 120,392.64 | 78,389.0 | View | |
| Aug 03, 2026 | EVP R&D, Chief Medical Officer | M | A | 104.0 | 19.34 | 2,011.36 | 73,493.0 | View | |
| Aug 03, 2026 | EVP, CLO, Alkermes, Inc. | S | D | 2,034.0 | 48.58 | 98,811.72 | 225,456.0 | View | |
| Jul 06, 2026 | EVP, CLO, Alkermes, Inc. | S | D | 2,034.0 | 54.03 | 109,897.02 | 227,490.0 | View | |
| Jul 01, 2026 | EVP R&D, Chief Medical Officer | M | D | 5,000.0 | 0.0 | 0.0 | 1,356.0 | View | |
| Jul 01, 2026 | EVP R&D, Chief Medical Officer | S | D | 700.0 | 52.1314 | 36,491.98 | 73,389.0 | View | |
| Jul 01, 2026 | EVP R&D, Chief Medical Officer | S | D | 8,300.0 | 51.4613 | 427,128.79 | 74,089.0 | View | |
| Jul 01, 2026 | EVP R&D, Chief Medical Officer | M | A | 5,000.0 | 19.34 | 96,700.0 | 82,389.0 | View | |
| Jun 12, 2026 | — | S | D | 2,000.0 | 45.1 | 90,200.0 | 25,680.0 | View | |
| Jun 04, 2026 | EVP, CLO, Alkermes, Inc. | S | D | 2,034.0 | 43.05 | 87,563.7 | 229,524.0 | View | |
| Jun 01, 2026 | EVP R&D, Chief Medical Officer | M | D | 5,000.0 | 0.0 | 0.0 | 6,356.0 | View | |
| Jun 01, 2026 | EVP R&D, Chief Medical Officer | S | D | 9,000.0 | 41.6715 | 375,043.5 | 77,389.0 | View | |
| Jun 01, 2026 | EVP R&D, Chief Medical Officer | M | A | 5,000.0 | 19.34 | 96,700.0 | 86,389.0 | View | |
| May 29, 2026 | VP, Finance (Interim PAO) | M | D | 12,825.0 | 0.0 | 0.0 | 12,826.0 | View | |
| May 29, 2026 | VP, Finance (Interim PAO) | M | D | 3,392.0 | 0.0 | 0.0 | 3,394.0 | View | |
| May 29, 2026 | VP, Finance (Interim PAO) | S | D | 16,217.0 | 42.3634 | 687,007.26 | 7,717.0 | View | |
| May 29, 2026 | VP, Finance (Interim PAO) | M | A | 12,825.0 | 19.34 | 248,035.5 | 23,934.0 | View | |
| May 29, 2026 | VP, Finance (Interim PAO) | M | A | 3,392.0 | 20.03 | 67,941.76 | 11,109.0 | View | |
| May 22, 2026 | — | M | D | 6,142.0 | — | — | 0.0 | View | |
| May 22, 2026 | — | A | A | 5,409.0 | 0.0 | 0.0 | 5,409.0 | View | |
| May 22, 2026 | — | A | A | 11,538.0 | 0.0 | 0.0 | 11,538.0 | View | |
| May 22, 2026 | — | F | D | 1,475.0 | 36.95 | 54,501.25 | 27,680.0 | View | |
| May 22, 2026 | — | M | A | 6,142.0 | — | — | 29,155.0 | View | |
| May 22, 2026 | — | M | D | 6,142.0 | — | — | 0.0 | View | |
| May 22, 2026 | — | A | A | 5,409.0 | 0.0 | 0.0 | 5,409.0 | View | |
| May 22, 2026 | — | A | A | 11,538.0 | 0.0 | 0.0 | 11,538.0 | View | |
| May 22, 2026 | — | F | D | 1,475.0 | 36.95 | 54,501.25 | 35,751.0 | View | |
| May 22, 2026 | — | M | A | 6,142.0 | — | — | 37,226.0 | View | |
| May 22, 2026 | — | M | D | 6,142.0 | — | — | 0.0 | View | |
| May 22, 2026 | — | A | A | 5,409.0 | 0.0 | 0.0 | 5,409.0 | View | |
| May 22, 2026 | — | A | A | 11,538.0 | 0.0 | 0.0 | 11,538.0 | View | |
| May 22, 2026 | — | F | D | 1,475.0 | 36.95 | 54,501.25 | 15,395.0 | View | |
| May 22, 2026 | — | M | A | 6,142.0 | — | — | 16,870.0 | View | |
| May 22, 2026 | — | M | D | 6,142.0 | — | — | 0.0 | View | |
| May 22, 2026 | — | A | A | 5,409.0 | 0.0 | 0.0 | 5,409.0 | View | |
| May 22, 2026 | — | A | A | 11,538.0 | 0.0 | 0.0 | 11,538.0 | View | |
| May 22, 2026 | — | F | D | 1,475.0 | 36.95 | 54,501.25 | 38,536.0 | View | |
| May 22, 2026 | — | M | A | 6,142.0 | — | — | 40,011.0 | View | |
| May 22, 2026 | — | M | D | 6,142.0 | — | — | 0.0 | View | |
| May 22, 2026 | — | A | A | 5,409.0 | 0.0 | 0.0 | 5,409.0 | View | |
| May 22, 2026 | — | A | A | 11,538.0 | 0.0 | 0.0 | 11,538.0 | View | |
| May 22, 2026 | — | F | D | 1,475.0 | 36.95 | 54,501.25 | 18,222.0 | View | |
| May 22, 2026 | — | M | A | 6,142.0 | — | — | 19,697.0 | View | |
| May 22, 2026 | — | M | D | 6,142.0 | — | — | 0.0 | View | |
| May 22, 2026 | — | A | A | 5,409.0 | 0.0 | 0.0 | 5,409.0 | View | |
| May 22, 2026 | — | A | A | 11,538.0 | 0.0 | 0.0 | 11,538.0 | View | |
| May 22, 2026 | — | F | D | 1,475.0 | 36.95 | 54,501.25 | 33,769.0 | View | |
| May 22, 2026 | — | M | A | 6,142.0 | — | — | 35,244.0 | View | |
| May 22, 2026 | — | A | A | 5,409.0 | 0.0 | 0.0 | 5,409.0 | View | |
| May 22, 2026 | — | A | A | 11,538.0 | 0.0 | 0.0 | 11,538.0 | View | |
| May 22, 2026 | — | A | A | 5,409.0 | 0.0 | 0.0 | 5,409.0 | View | |
| May 22, 2026 | — | A | A | 11,538.0 | 0.0 | 0.0 | 11,538.0 | View | |
| May 22, 2026 | — | M | D | 6,142.0 | — | — | 0.0 | View | |
| May 22, 2026 | — | A | A | 5,409.0 | 0.0 | 0.0 | 5,409.0 | View | |
| May 22, 2026 | — | A | A | 11,538.0 | 0.0 | 0.0 | 11,538.0 | View | |
| May 22, 2026 | — | F | D | 1,475.0 | 36.95 | 54,501.25 | 35,751.0 | View | |
| May 22, 2026 | — | M | A | 6,142.0 | — | — | 37,226.0 | View | |
| May 22, 2026 | — | M | D | 6,142.0 | — | — | 0.0 | View | |
| May 22, 2026 | — | A | A | 5,409.0 | 0.0 | 0.0 | 5,409.0 | View | |
| May 22, 2026 | — | A | A | 11,538.0 | 0.0 | 0.0 | 11,538.0 | View | |
| May 22, 2026 | — | F | D | 3,207.0 | 36.95 | 118,498.65 | 106,679.0 | View | |
| May 22, 2026 | — | M | A | 6,142.0 | — | — | 109,886.0 | View | |
| May 04, 2026 | EVP, CLO, Alkermes, Inc. | S | D | 2,034.0 | 33.2 | 67,528.8 | 231,558.0 | View | |
| May 01, 2026 | EVP R&D, Chief Medical Officer | M | D | 5,000.0 | 0.0 | 0.0 | 11,356.0 | View | |
| May 01, 2026 | EVP R&D, Chief Medical Officer | S | D | 9,000.0 | 33.3955 | 300,559.5 | 81,389.0 | View | |
| May 01, 2026 | EVP R&D, Chief Medical Officer | M | A | 5,000.0 | 19.34 | 96,700.0 | 90,389.0 | View |